| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |